Cencora (NYSE:COR), formerly known as AmerisourceBergen until its rebranding in early 2024, is a global pharmaceutical sourcing and distribution company that provides a broad range of services to healthcare providers, pharmaceutical manufacturers and patients. Through its extensive logistics network, Cencora distributes branded, generic and specialty pharmaceuticals, as well as over-the-counter medical products, vaccines and biosimilars. The company’s offerings extend to value-added services such as patient assistance programs, infusion support, and consulting for regulatory and supply-chain optimization.
The company operates through two primary segments: the global distribution business, which supplies drugs and related healthcare products to hospitals, retail pharmacies and long-term care facilities; and the specialty solutions business, which focuses on high-growth areas such as oncology, rare diseases and complex therapies. In addition to traditional wholesale distribution, Cencora delivers hub services, reimbursement support and specialty pharmacy services designed to improve patient outcomes and streamline treatment pathways.
Founded in 2001 via the merger of Bergen Brunswig and AmeriSource Health, Cencora has grown through strategic acquisitions and partnerships to strengthen its position in key markets. Over the years, the company has expanded its footprint beyond North America to serve customers in Europe, Asia Pacific and other international regions. Its state-of-the-art distribution centers and cold-chain capabilities ensure secure, efficient delivery of sensitive pharmaceutical products.
Headquartered in Chesterbrook, Pennsylvania, Cencora is led by Chief Executive Officer Steven H. Collis, who has steered the organization through significant industry shifts and its recent corporate rebranding. Under his leadership, the company continues to focus on innovation, operational excellence and collaboration with healthcare stakeholders to address global public health challenges and support the evolving needs of patients and providers.
